These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7040093)

  • 21. FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.
    Blazar BR; Taylor PA; Fitzsimmons WE; Vallera DA
    J Immunol; 1994 Aug; 153(4):1836-46. PubMed ID: 7519216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphokine production in vivo in a murine graft-versus-host reaction.
    Troutt AB; Kelso A
    Transplant Proc; 1992 Oct; 24(5):2317. PubMed ID: 1413076
    [No Abstract]   [Full Text] [Related]  

  • 23. Transient graft-versus-host reaction in the treatment of leukemia in mice.
    Boranić M
    J Natl Cancer Inst; 1968 Aug; 41(2):421-37. PubMed ID: 4876445
    [No Abstract]   [Full Text] [Related]  

  • 24. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T lymphocytes determine the development of xeno GVHD and of human hemopoiesis in NOD/SCID mice following human umbilical cord blood transplantation.
    Verlinden SF; Mulder AH; de Leeuw JP; van Bekkum DW
    Stem Cells; 1998; 16 Suppl 1():205-17. PubMed ID: 11012164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-tolerance restoration of irradiated graft-versus-host mice after thymus grafting.
    Baron C; Bierre V; Weil B; Lang P
    Transplant Proc; 1995 Aug; 27(4):2486-7. PubMed ID: 7652898
    [No Abstract]   [Full Text] [Related]  

  • 27. Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host.
    Hummel S; Wilms D; Vitacolonna M; Zöller M
    J Leukoc Biol; 2002 Nov; 72(5):898-912. PubMed ID: 12429711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential sensitivity of T lymphocytes and hematopoietic precursor cells to photochemotherapy with 8-methoxypsoralen and ultraviolet A light.
    Mabed M; Coffe C; Racadot E; Angonin R; Pavey JJ; Tiberghien P; Herve P
    Ann Hematol; 2006 Jan; 85(1):17-24. PubMed ID: 16208471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB; Elkin G; Khitrin S; Slavin S
    Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
    Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
    J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. F1 hybrid resistance and self-tolerance in graft-versus-host mice.
    Baron C; Bierre V; Weil B; Lang P
    Transplant Proc; 1996 Oct; 28(5):2921-2. PubMed ID: 8908125
    [No Abstract]   [Full Text] [Related]  

  • 33. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two distinct types of late onset graft-versus-host disease after bone marrow transplantation in lethally irradiated mice.
    Heidt PJ; Wagemaker G; Knaan-Shanzer S; van Bekkum DW
    Transplantation; 1981 Sep; 32(3):263-4. PubMed ID: 7025379
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine.
    Anderson LD; Petropoulos D; Everse LA; Mullen CA
    Cancer Res; 1999 Apr; 59(7):1525-30. PubMed ID: 10197624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Graft-versus-host reactions: models, susceptibility to control, and clinical analogies].
    Brune K
    Schweiz Med Wochenschr; 1970 Jan; 100(2):49-58. PubMed ID: 4400853
    [No Abstract]   [Full Text] [Related]  

  • 37. Interferon-gamma-mediated prevention of graft-versus-host disease: development of immune competent and allo-tolerant T cells in chimeric mice.
    Brok HP; Vossen JM; Heidt PJ
    Bone Marrow Transplant; 1997 Mar; 19(6):601-6. PubMed ID: 9085739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes.
    Margalit M; Ilan Y; Ohana M; Safadi R; Alper R; Sherman Y; Doviner V; Rabbani E; Engelhardt D; Nagler A
    Bone Marrow Transplant; 2005 Jan; 35(2):191-7. PubMed ID: 15558045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in graft--ersus-host reactivity and peripheral leukocytes in mice after erythropoietin treatment.
    Kinnamon KE; Blackwell LH; Ledney GD
    Exp Hematol; 1975 Aug; 3(4):234-43. PubMed ID: 240732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.
    Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S
    J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.